Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Cantor Fitzgerald
Citi
McKesson
Julphar
Moodys
US Army
Fuji
Dow

Generated: January 21, 2019

DrugPatentWatch Database Preview

Sargramostim - Biologic Drug Details

« Back to Dashboard

Summary for sargramostim
Tradenames:1
Patents:104
Applicants:1
BLAs:1
Suppliers: see list2
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for sargramostim

US Patents for sargramostim

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Berlex Labs LEUKINE sargramostim VIAL 103362 001 1991-03-05 ➤ Try a Free Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) ➤ Try a Free Trial RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 001 1991-03-05 ➤ Try a Free Trial YALE UNIVERSITY (New Haven, CT) ➤ Try a Free Trial RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 001 1991-03-05 ➤ Try a Free Trial University of the Sciences of Philadelphia (Philadelphia, PA) ➤ Try a Free Trial RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 001 1991-03-05 ➤ Try a Free Trial Reponex Pharmaceuticals A/S (Horsholm, DK) ➤ Try a Free Trial RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 001 1991-03-05 ➤ Try a Free Trial YALE UNIVERSITY (New Haven, CT) ➤ Try a Free Trial RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 001 1991-03-05 ➤ Try a Free Trial The Regents of the University of California (Oakland, CA) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for sargramostim

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
14C/052 Belgium ➤ Try a Free Trial PRODUCT NAME: SILTUXIMAB; AUTHORISATION NUMBER AND DATE: EU/1/14/928/001 20140527
14/048 Ireland ➤ Try a Free Trial PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: EU/1/14/928/001-002 20140522
00687 Netherlands ➤ Try a Free Trial PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: EU/1/14/928/001-002 20140522
/2014 Austria ➤ Try a Free Trial PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: EU/1/14/928 20140522
0140027 00115 Estonia ➤ Try a Free Trial PRODUCT NAME: SILTUKSIMAB;REG NO/DATE: K(2014)3557 (LOPLIK) 27.05.2014
2014000084 Germany ➤ Try a Free Trial PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: EU/1/14/928 20140522
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Express Scripts
UBS
McKinsey
Baxter
Chinese Patent Office
Julphar
Dow
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.